What is SpectrumAI?
SpectrumAI operates at the intersection of healthcare technology and artificial intelligence, providing specialized software for Applied Behavior Analysis (ABA) and behavioral health providers. The company's core value proposition lies in its ability to integrate clinical decision support with Electronic Health Record (EHR) functionality. By utilizing advanced analytics, SpectrumAI enables therapy organizations to move beyond manual processes, fostering a data-driven environment that enhances care quality and operational efficiency. The platform is designed to address the unique complexities of behavioral health, ensuring that providers can deliver consistent, evidence-based interventions while optimizing their internal resource allocation.
How much funding has SpectrumAI raised?
SpectrumAI has raised a total of $29M across 2 funding rounds:
Angel/Seed
$9M
Series A
$20M
Angel/Seed (2022): $9M with participation from F-Prime Capital Partners, Frist Cressey Ventures, and The Autism Impact Fund
Series A (2023): $20M led by Cobalt Ventures
Key Investors in SpectrumAI
F-Prime Capital Partners
A venture firm with a deep bench of engineers and clinicians, focusing on high-impact investments across the healthcare and technology landscape.
Frist Cressey Ventures
A specialized venture capital firm dedicated to accelerating innovative companies that drive systemic improvements in healthcare delivery and patient outcomes.
The Autism Impact Fund
An impact-focused investment firm targeting behavioral health, mental health, and neurodevelopmental disorders to improve care accessibility and outcomes.
What's next for SpectrumAI?
With the infusion of this recent capital, SpectrumAI is poised to expand its market footprint and deepen its product capabilities. The strategic focus will likely center on scaling its EHR integration features and enhancing the predictive analytics engine that powers its clinical decision support tools. As the behavioral health industry continues to undergo digital transformation, SpectrumAI is positioned to become a foundational partner for large-scale therapy networks. Future growth will likely involve deepening partnerships with health systems and insurance payers to ensure that their AI-driven insights are seamlessly integrated into the broader continuum of care, ultimately driving down costs and improving accessibility for neurodiverse populations.
See full SpectrumAI company page
